In a study by Viziteu et al. focusing on multiple myeloma cells, RECQL1 overexpression was significantly higher in primary myeloma cells from newly diagnosed patients compared to normal bone marrow plasma cells (Viziteu et al., 2016). The gene discussed is RECQL; the disease is plasma cell myeloma.